Product
Campath
2 clinical trials
3 indications
Indication
SclerodermaIndication
Mycosis FungoidesIndication
Sezary SyndromeClinical trial
Campath-1h as Immunoablative Therapy for Children and Adolescents With Treatment Refractory Systemic SclerosisStatus: Withdrawn, Estimated PCD: 2018-08-02
Clinical trial
A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning With Campath-1HStatus: Completed, Estimated PCD: 2019-01-24